Impact of Switching from Double-Blind Placebo or Entacapone to Open-Label Opicapone in Non-Motor Symptoms Scale: Results from the 1-Year Extension Bipark-I Study
AuthID
P-00Q-VZ9
P-00Q-VZ9
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service